Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort

Background: Pleomorphic dermal sarcoma (PDS) is a rare, cutaneous sarcoma predominantly affecting sun-exposed skin in elderly patients. Surgical excision remains the mainstay of treatment, but evidence on optimal management and long-term outcomes is limited. Methods: We retrospectively analyzed 1069 patients diagnosed with PDS between 2009 and 2025 using data from the Baden-Württemberg Cancer Registry, Germany. Patient characteristics, surgical management, resection status, and preceding malignancies were evaluated. Temporal surgical trends were assessed using multivariable logistic regression. Overall survival (OS) was analyzed using Kaplan–Meier estimates and multivariable Cox regression. Results: Median age was 82 years, and 83.7% of patients were male. The hair-bearing scalp was the most frequent tumor site (55.0%). Among 449 patients with documented surgical procedures, 82.0% underwent micrographically controlled surgery (MGC), with increasing use over time (adjusted OR per year, 1.19; 95% CI, 1.11–1.29). R0-resections were comparable between MGC and conventional resection (75.7% vs. 71.6%). Among 679 patients evaluated for preceding malignancies, 39.7% had a documented cancer history, including 4.4% with hematologic malignancies. Among 723 patients with reliable follow-up, median OS was 72.4 months (95% CI, 61.3–82.1). Mortality was strongly associated with age, but not anatomical tumor site. Surgical approach was not significantly associated with OS after adjustment (MGC vs. conventional resection: HR, 1.49; 95% CI, 0.95–2.3; p = 0.083). Conclusions: This large registry-based study provides real-world evidence on PDS management and prognosis. The increasing adoption of MGC supports its growing role in clinical practice, while the high frequency of preceding malignancies highlights the complex oncological history of patients with PDS.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-18
DOI
https://doi.org/10.3390/cancers18223690
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort

Jochen Sven Utikal, Christiane Bauer‐Auch, Philipp Morakis, Sebastian A. Wohlfeil et al.
3 links
Cancers
Sarcoma Diagnosis and Treatment
article

Pleomorphic Dermal Sarcoma: Clinical Characteristics, Surgical Management, and Long-Term Outcomes in a Large Registry-Based Cohort

Jochen Sven Utikal, Christiane Bauer‐Auch, Philipp Morakis, Sebastian A. Wohlfeil, Irina Surovtsova, Corinne Hübers, Cigdem Oswald, Amelie Braun, Heike Hereth
article en

Abstract

Background: Pleomorphic dermal sarcoma (PDS) is a rare, cutaneous sarcoma predominantly affecting sun-exposed skin in elderly patients. Surgical excision remains the mainstay of treatment, but evidence on optimal management and long-term outcomes is limited. Methods: We retrospectively analyzed 1069 patients diagnosed with PDS between 2009 and 2025 using data from the Baden-Württemberg Cancer Registry, Germany. Patient characteristics, surgical management, resection status, and preceding malignancies were evaluated. Temporal surgical trends were assessed using multivariable logistic regression. Overall survival (OS) was analyzed using Kaplan–Meier estimates and multivariable Cox regression. Results: Median age was 82 years, and 83.7% of patients were male. The hair-bearing scalp was the most frequent tumor site (55.0%). Among 449 patients with documented surgical procedures, 82.0% underwent micrographically controlled surgery (MGC), with increasing use over time (adjusted OR per year, 1.19; 95% CI, 1.11–1.29). R0-resections were comparable between MGC and conventional resection (75.7% vs. 71.6%). Among 679 patients evaluated for preceding malignancies, 39.7% had a documented cancer history, including 4.4% with hematologic malignancies. Among 723 patients with reliable follow-up, median OS was 72.4 months (95% CI, 61.3–82.1). Mortality was strongly associated with age, but not anatomical tumor site. Surgical approach was not significantly associated with OS after adjustment (MGC vs. conventional resection: HR, 1.49; 95% CI, 0.95–2.3; p = 0.083). Conclusions: This large registry-based study provides real-world evidence on PDS management and prognosis. The increasing adoption of MGC supports its growing role in clinical practice, while the high frequency of preceding malignancies highlights the complex oncological history of patients with PDS.

CancersVol. 18(22)
German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), University Medical Centre Mannheim (DE), Krebsregister Baden-Württemberg (DE)
Good health and well-being
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon